Skip to content
    Inve.money
    Earnings calls

    Granules India Limited concall ledger

    Every earnings call for GRANULES — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    GRANULES · 8 transcripts · Healthcare · latest Q1 FY27

    Granules India Limited has 8 earnings calls on record here, a Healthcare company, most recently Q1 FY27. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

    Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

    GRANULES Q1 FY26 Earnings Call Transcript & Analysis

    Revenue12,101 million+3% YoYEBITDA2,467 million−5% YoYEBITDA Margin20.4%Gross Margin64.9%Net Debt9,480 million

    Revenue 12101 million (+3% YoY); EBITDA 2467 million (−5% YoY); EBITDA Margin 20.4%. Revenue for Q1 FY26 stood at ₹12,101 million, reflecting a 3% YoY growth and 1% QoQ growth.

    Read full transcript & analysis
    Q4 FY25Published 28 May 2025Call held 28 May 2025

    GRANULES Q4 FY25 Earnings Call Transcript & Analysis

    Revenue11,974 million+2% YoYEBITDA2,524 million−1% YoYEBITDA Margin21.1%−1% YoYGross Margin63.4%+3% YoYNet Debt7,061 million

    Revenue 11974 million (+2% YoY); EBITDA 2524 million (−1% YoY); EBITDA Margin 21.1% (−1% YoY). Q4 FY25 Revenue stood at ₹11,974 million, marking a 2% YoY growth and 5% QoQ growth.

    Read full transcript & analysis
    Q3 FY25Published 24 Jan 2025Call held 24 Jan 2025

    GRANULES Q3 FY25 Earnings Call Transcript & Analysis

    Revenue11,377 million−2% YoYEBITDA2,303 million−8% YoYEBITDA Margin20.2%Gross Margin61.7%Net Debt8,289 million

    Revenue 11377 million (−2% YoY); EBITDA 2303 million (−8% YoY); EBITDA Margin 20.2%. Q3 FY25 Revenue stood at INR 11,377 million, a 2% decline YoY but an 18% increase QoQ.

    Read full transcript & analysis